Prediction Markets Signal Potential Federal Reserve Rate Hike by July 2027
M R Maniveni Foods IPO Allotment Date Expected Today Steps to Check Status
Piper Sandler Warns Strait of Hormuz Closure Could Drive Oil Prices to Historic Levels
Trump Mobile Probes Potential Data Exposure Affecting Thousands of Prospective Customers
London Tour Operators See Shifting Demand From Landmark Tours to HighSpeed Thames Rides
Legence Corp LGN Sees Positive Q1 Momentum Source Report Highlights
SU Q1 2026 Earnings Strong EPS Beat Highlights Operational Efficiency Amid Market Challenges
Protara Therapeutics Q1 2026 Earnings NarrowerthanExpected Loss as Pipeline Advances
DTB Q1 2026 Earnings EPS Falls Short of Expectations Amid Flat Market Response
CLS Q1 2026 Earnings Beat and Raise as Celestica Delivers Strong EPS Surprise
CPSH Q1 2026 Earnings EPS Misses Estimates Amid Revenue Disclosure Gap
ResMed Inc RMD Q1 2026 Earnings EPS Beat Driven by Strong Operating Leverage Stock Edges Lower
Foremost Clean Energy FMST Dips Nearly 3 Key Support Level in Focus
Immatics IMTX Gains Ground Biotech Stock Tests Key Resistance at 1196
Oaktree Acquisition Corp III Life Sciences OACC Holds Steady Near 1070 as SPAC Investors Await Transaction Announcement
CBRE Group CBRE Slips 14 as Real Estate Sector Faces Mixed Signals
Launch Two Acquisition Corp LPBB Trading Near Trust Value as Shares Hold Steady
SCHMID Group Warrants SHMDW Decline 7 as Selling Pressure Intensifies Key Support Level in Focus
Avidbank Holdings AVBH Inches Higher as Shares Hold Above Key Support
Jazz Pharmaceuticals JAZZ Experiences Modest Decline Following Recent RunUp
Neumora Therapeutics NMRA Edges Lower as Stock Tests Key Support at 175
K2 Capital Acquisition Rights KTWOR Jump 1579 as Speculation Builds Around Potential Merger Completion
Osprey Bitcoin Trust OBTC Holds Steady Near Key Resistance Amid Cryptocurrency Tailwinds
Stock Index Futures Rise as AI Momentum and Geopolitical Optimism Fuel Rally
ONE Gas Inc OGS Q1 2026 Earnings EPS Misses Estimates Yet Shares Edge Higher
Royalty Pharma RPRX Holds Ground Near Midpoint Steady Trading in Tight Range